HIV Status does not Impact on Outcome in Patients with Hodgkin Lymphoma Treated with ABVD Chemotherapy in the HAART Era

HIV Status does not Impact on Outcome in Patients with Hodgkin Lymphoma Treated with ABVD Chemotherapy in the HAART Era

Hiển thị phiên bản (1) khác

Chi tiết về thư mục
Những tác giả chính:	Orkin, C, Montoto, S, Shaw, K, Okosun, J, Gandhi, S, Fields, P, Wilson, A, Shanyinde, M, Cwynarski, K, Marcus, R, De Vos, J, Young, A, Tenant-Flowers, M, Johnson, M, Chilton, D, Gribben, J, Bower, M
Định dạng:	Journal article
Được phát hành:	2012

Những quyển sách tương tự

HIV Status Does Not Impact on Outcome in Patients with Hodgkin Lymphoma Treated with ABVD Chemotherapy in the HAART Era
Bằng: Montoto, S, et al.
Được phát hành: (2011)

HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era.
Bằng: Montoto, S, et al.
Được phát hành: (2012)

Neutropenia and Neutropenic Complications in ABVD Chemotherapy for Hodgkin Lymphoma
Bằng: Bhanu Vakkalanka, et al.
Được phát hành: (2011-01-01)

The Use of Filgrastim in Patients with Hodgkin Lymphoma Receiving ABVD
Bằng: Adam F. Binder, et al.
Được phát hành: (2017-10-01)

Interim PET-directed therapy in limited-stage Hodgkin lymphoma initially treated with ABVD
Bằng: Diego Villa, et al.
Được phát hành: (2018-12-01)

Tissue is the issue-sarcoidosis following ABVD chemotherapy for Hodgkin's lymphoma: a case report
Bằng: Subbiah Vivek, et al.
Được phát hành: (2007-11-01)

S202: CHILDBEARING AMONG CLASSICAL HODGKIN LYMPHOMA SURVIVORS TREATED WITH BEACOPP AND ABVD IN SWEDEN, DENMARK, AND NORWAY
Bằng: J. P. Entrop, et al.
Được phát hành: (2022-06-01)

ABVD plus rituximab versus ABVD alone for advanced stage, high-risk classical Hodgkin lymphoma: a randomized phase 2 study
Bằng: Paolo Strati, et al.
Được phát hành: (2019-02-01)

A case of blood triglyceride increased induced by ABVD therapy for classical Hodgkin lymphoma
Bằng: Ryo Yonezawa, et al.
Được phát hành: (2023-01-01)

Hodgkin lymphoma treatment with ABVD in the US and the EU: neutropenia occurrence and impaired chemotherapy delivery
Bằng: Schwenkglenks Matthias, et al.
Được phát hành: (2010-08-01)

Maternal ABVD chemotherapy for Hodgkin lymphoma in a dichorionic diamniotic pregnancy: a case report
Bằng: Camille Cotteret, et al.
Được phát hành: (2020-04-01)

Safety, efficacy, and affordability of ABVD for Hodgkin lymphoma in Malawi: a prospective cohort studyResearch in context
Bằng: Marriam Mponda, et al.
Được phát hành: (2024-03-01)

Treatment of Hodgkin Lymphoma With ABVD Chemotherapy in Rural Rwanda: A Model for Cancer Care Delivery Implementation
Bằng: Rebecca J. DeBoer, et al.
Được phát hành: (2020-11-01)

Advanced Hodgkin's lymphoma: results in 216 patients treated with ABVD in Brazil Linfoma de Hodgkin em estádio avançado: resultados do tratamento em 216 pacientes tratados com ABVD no Brasil
Bằng: Luciana Britto, et al.
Được phát hành: (2010-01-01)

Body mass index-associated responses to an ABVD-like regimen in newly-diagnosed patients with Hodgkin lymphoma
Bằng: Min Hu, et al.
Được phát hành: (2023-08-01)

T065: Reproduction patterns among Classical Hodgkin Lymphoma Survivors Treated with BEACOPP and ABVD in Sweden, Denmark, and Norway
Bằng: Joshua P. Entrop, et al.
Được phát hành: (2022-10-01)

PB2260: FIVE-YEAR SINGLE-CENTER EXPERIENCE IN THE TREATMENT OF ADVANCED STAGE CLASSICAL HODGKIN LYMPHOMA WITH ABVD
Bằng: Vojin Vukovic, et al.
Được phát hành: (2023-08-01)

Clinical profile and outcome of classical Hodgkin lymphoma treated with ABVD protocol at Homi Bhabha Cancer Hospital Varanasi
Bằng: NIKITA SINGH, et al.
Được phát hành: (2022-01-01)

A case of Hodgkin’s lymphoma with severely impaired liver function treated successfully with gemcitabine followed by ABVD
Bằng: Chakraborty R, et al.
Được phát hành: (2015-03-01)

P023: PET2-adapted approach after 2 cycles of ABVD is comparable to 2 cycles of BEACOPP escalated and 2 cycles of ABVD and irradiation in early unfavorable Hodgkin lymphoma
Bằng: Heidi Mocikova, et al.
Được phát hành: (2022-10-01)

Does Interim PET Scan After 2 Cycles of ABVD Predict Outcome in Hodgkin Lymphoma? Real-World Evidence
Bằng: Arun Seshachalam, et al.
Được phát hành: (2019-12-01)

Partial omission of bleomycin for early‐stage Hodgkin lymphoma patients treated with combined modality therapy: Does incomplete ABVD lead to inferior outcomes?
Bằng: Jillian R. Gunther, et al.
Được phát hành: (2020-07-01)

Expression of FOXP3, CD68, and CD20 at diagnosis in the microenvironment of classical Hodgkin lymphoma is predictive of outcome.
Bằng: Greaves, P, et al.
Được phát hành: (2013)

P033 (0007) SINGLE CENTER ANALYSIS OF NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA: FOCUS ON R-ABVD AND INTERIM PET
Được phát hành: (2018-10-01)

Long‐term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trials
Bằng: Marc P. E. André, et al.
Được phát hành: (2020-09-01)

Baseline prognostic predictors in classical Hodgkin Lymphoma: a retrospective, single-center analysis on patients treated with PET/CT-guided ABVD
Bằng: Alessandro Cellini, et al.
Được phát hành: (2024-09-01)

Brentuximab vedotin followed by ABVD +/− radiotherapy in patients with previously untreated Hodgkin lymphoma: final results of a pilot phase II study
Bằng: Massimo Federico, et al.
Được phát hành: (2016-04-01)

Survival rates of adult patients with Hodgkin lymphoma who underwent ABVD versus escalated BEACOPP in a resource‐limited country: An observational study
Bằng: Tawatchai Suwanban, et al.
Được phát hành: (2023-08-01)

P1081: PET-ADAPTED THERAPY AFTER THREE CYCLES OF ABVD FOR ALL STAGES OF HODGKIN LYMPHOMA: LONG TERM FOLLOW UP OF THE GATLA LH-05 TRIAL
Bằng: A. Pavlovsky, et al.
Được phát hành: (2022-06-01)

Influência do CD 20 na refratariedade do linfoma de Hodgkin clássico ao tratamento inicial com o esquema ABVD, no Ceará, Brasil Influence of CD 20 antigen expression in the refractoriness of classical Hodgkin lymphoma in the first line treatment with ABVD protocol in Ceará state, Brazil
Bằng: Rogério Pinto Giesta, et al.
Được phát hành: (2009-06-01)

FDG-PET in bleomycin-induced pneumonitis following ABVD chemotherapy for Hodgkin’s disease-a useful tool for monitoring pulmonary toxicity and disease activity
Bằng: T. Buchler, et al.
Được phát hành: (2007-11-01)

A comparison of clinical profile and treatment outcome of Hodgkin’s Lymphoma in Tanzania according to HIV status during the HAART era
Bằng: Mercy M. Mbai, et al.
Được phát hành: (2024-07-01)

Pilot study of lung cancer screening for survivors of Hodgkin lymphoma
Bằng: Rachel Broadbent, et al.
Được phát hành: (2023-11-01)

P030 (0143) ONCE-A-CYCLE VS. DAILY G-CSF IN EARLY-UNFAVORABLE STAGES OF HODGKIN LYMPHOMA TREATED WITH BEACOPP ESCALATED FOLLOWED BY ABVD
Được phát hành: (2018-10-01)

P1082: SAFETY AND EFFICACY ANALYSIS IN OLDER PATIENTS TREATED WITHIN THE GATLA LH-05 PROTOCOL: PET-ADAPTED THERAPY AFTER 3 CYCLES OF ABVD FOR ALL STAGES OF HODGKIN LYMPHOMA
Bằng: N. L. Fiad, et al.
Được phát hành: (2022-06-01)

THE RISK OF THERAPY-RELATED MYELODYSPLASIA/ACUTE MYELOID LEUKEMIA IN HODGKIN LYMPHOMA HAS SUBSTANTIALLY DECREASED IN THE ABVD ERA ABOLISHING MECHLORETHAMINE AND PROCARBAZINE AND LIMITING VOLUMES AND DOSES OF RADIOTHERAPY
Bằng: Ercole Brusamolino, et al.
Được phát hành: (2012-04-01)

THE RISK OF THERAPY-RELATED MYELODYSPLASIA/ACUTE MYELOID LEUKEMIA IN HODGKIN LYMPHOMA HAS SUBSTANTIALLY DECREASED IN THE ABVD ERA ABOLISHING MECHLORETAMINE AND PROCARBAZINE AND LIMITING VOLUMES AND DOSES OF RADIOTHERAPY
Bằng: Ercole Brusamolino, et al.
Được phát hành: (2014-08-01)

THE RISK OF THERAPY-RELATED MYELODYSPLASIA/ACUTE MYELOID LEUKEMIA IN HODGKIN LYMPHOMA HAS SUBSTANTIALLY DECREASED IN THE ABVD ERA ABOLISHING MECHLORETHAMINE AND PROCARBAZINE AND LIMITING VOLUMES AND DOSES OF RADIOTHERAPY
Bằng: Ercole Brusamolino, et al.
Được phát hành: (2012-01-01)

THE RISK OF THERAPY-RELATED MYELODYSPLASIA/ACUTE MYELOID LEUKEMIA IN HODGKIN LYMPHOMA HAS SUBSTANTIALLY DECREASED IN THE ABVD ERA ABOLISHING MECHLORETHAMINE AND PROCARBAZINE AND LIMITING VOLUMES AND DOSES OF RADIOTHERAPY
Bằng: Ercole Brusamolino, et al.
Được phát hành: (2014-08-01)

P1066: PEMBROLIZUMAB MONOTHERAPY AS A FIRST THERAPY FOR HODGKIN LYMPHOMA IS DELIVERABLE IN OLDER OR ABVD INELIGIBLE PATIENTS, DOES NOT PRECLUDE SUBSEQUENT THERAPY, AND PROVIDES ADEQUATE SURVIVAL.
Bằng: Michael Dickinson, et al.
Được phát hành: (2023-08-01)